Current opinion in obstetrics & gynecologyHumansFemaleImmunoconjugatesOvarian NeoplasmsBreast Neoplasms
Trastuzumab deruxtecan and the evolving role of human epidermal growth factor receptor 2-targeted antibody-drug conjugates in breast and ovarian cancer.
Shivani K Thaker, Jordyn Silverstein, Gottfried E Konecny, Aditya Bardia
Published: 202610.1097/GCO.0000000000001080
Abstract
PURPOSE OF REVIEW: Breast cancer remains a leading cause of cancer-related morbidity and mortality worldwide. One of the most significant advances in treatment has been the evolution of human epidermal growth factor receptor 2 (HER2)-targeted therapi…
Preview only. Read the full abstract at the source